Human Investing’s Treace Medical Concepts TMCI Stock Holding History

Human Investing’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,671	Closed	-$12.4K	–	269
2024 Q4	$12.4K	Buy	+1,671	New	+$11.2K	﹤0.01%	204

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Human Investing's TMCI Position: Q1 2025 in Review

Human Investing sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 1,671 shares — an estimated $12.4K sold.

Human Investing first reported a position in TMCI in Q4 2024 and held it in 1 quarter. The position peaked at $12.4K in Q4 2024. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

Human Investing reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
Human Investing sold 1,671 Treace Medical Concepts shares in Q1 2025, an estimated $12.4K.
Human Investing first reported a position in Treace Medical Concepts in Q4 2024 and held it in 1 quarter.
Human Investing's Treace Medical Concepts position peaked at $12.4K in Q4 2024.
138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Human Investing's 13F filing for Q1 2025, filed 15 May 2025.